Tweet

ProPhotonix Limited: ProPhotonix Awarded a Two-Year Supply Agreement

SALEM, NH — (Marketwired) — 05/07/15 — ProPhotonix Limited (OTC PINK: STKR) (LSE: PPIX) (LSE: PPIR)

(Salem, New Hampshire, May 7, 2015) ProPhotonix Limited (OTC: STKR and
London Stock Exchange – AIM: PPIX and PPIR),a designer and
manufacturer of LED illumination systems and laser diode modules with
operations in Ireland and the United Kingdom, today announces the award
of a two year supply agreement, for custom LED illumination devices,
from a leading global manufacturer of drug delivery products.
Deliveries are expected to begin in the second half 2015 and continue
through May 2017.

The LED illuminator, consisting of 100–s of LEDs with an input power of
>1 kilowatt, is designed with a dynamic operating current range from 1
milliamp (“mA”) up to 10,000mA with a 1mA resolution precision. Heat
dissipation from the LEDs is approximately 600 watts requiring a
reliable water-cooled heat management system. The illuminator operates
in either continuous mode or strobe mode (200Hz, 10% duty cycle).
Complex software manages multichannel control and monitoring, thermal
management, and other such operating protection features.

The supply agreement does not stipulate or require that the customer
makes any purchases. The expected revenue to the Company, during the
term of the agreement, could be EUR975,000 if fulfilled at the expected
quantities.

Commenting on the Agreement, David McGuinness, Sales Director – EMEA,
of ProPhotonix Limited said, “This is a second generation product for
the customer and the result of several years of development by our LED
engineering team. The successful product began with customer
collaboration, a custom design, prototype devices, and ultimately
production ready illuminators. The application of this ProPhotonix
illuminator is to ensure the efficacy of the end product in a
production environment running at speeds of up to 100 units per
second. We are delighted to provide unique custom solutions for our
customers, enabling competitive advantage in their respective markets.”

Tim Losik, President and CEO of ProPhotonix stated, “This project
illustrates an ever increasing trend ProPhotonix is seeing, where it is
an absolute necessity to have in-house engineering design expertise in
optics, electronics, mechanics, materials, software and manufacturing
and for compete integration between these functional areas to meet
customers– specification and target price. With over 15 years
experience in Custom LED and Laser Module design, ProPhotonix delivers
such solutions across the wide range of industries we supply including
the dental, medical and pharmaceutical industries.”

ProPhotonix Limited, headquartered in Salem, New Hampshire, is an
independent designer and manufacturer of diode-based laser modules and
LED systems for industry leading OEMs and medical equipment companies.
In addition, the Company distributes premium diodes for Ushio (formerly
Opnext), Osram, QSI, Panasonic, and Sony. The Company serves a wide
range of markets including the machine vision, industrial inspection,
security, and medical markets. ProPhotonix has offices and subsidiaries
in the U.S., Ireland, U.K., and Europe. For more information about
ProPhotonix and its innovative products, visit the Company–s web site
at

This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of
the Securities Exchange Act of 1934. All statements other than
statements of historical fact, including without limitation, those with
respect to ProPhotonix–s goals, plans and strategies set forth herein
are forward-looking statements. The following important factors and
uncertainties, among others, could cause actual results to differ
materially from those described in these forward-looking statements:
uncertainty that cash balances may not be sufficient to allow
ProPhotonix to meet all of its business goals; uncertainty that
ProPhotonix–s new products will gain market acceptance; the risk that
delays and unanticipated expenses in developing new products could
delay the commercial release of those products and affect revenue
estimates; the risk that one of our competitors could develop and bring
to market a technology that is superior to those products that we are
currently developing; and ProPhotonix–s ability to capitalize on its
significant research and development efforts by successfully marketing
those products that the Company develops. Forward-looking statements
represent management–s current expectations and are inherently
uncertain. All Company, brand, and product names are trademarks or
registered trademarks of their respective holders. ProPhotonix
undertakes no duty to update any of these forward-looking statements.

#######

Contacts:
RNS
Customer
Services
0044-207797-4400